Opioid Abatement Funds and MOUD Use: Null Main Effects, Exploratory Signal
This state-level policy evaluation tests whether opioid settlement dollars have increased medication for opioid use disorder (MOUD) uptake, and why non-supplantation rules may matter to stewardship pharmacists.
📅 Journal publication: Dec 2026·Last updated: Nov 5, 2026
opioid abatement fundsopioid settlementmedications for opioid use disorderMOUDbuprenorphinemethadonesupplantationsynthetic difference-in-differenceshealth policyopioid stewardshipquasi-experimentalBehavioral Health / Addiction Medicine
Background Information
How state spending influences opioid use disorder treatment admissions.
This study explores how state-level opioid abatement fund allocations impact the utilization of medications for opioid use disorder (MOUD). Funding to general treatment programs increased substance use treatment admissions by 13.2% but not MOUD utilization. In states prohibiting fund supplantation, MOUD admissions increased significantly. The findings suggest that appropriate allocation of funds, particularly in states prohibiting supplantation, could enhance MOUD use; however, results are based on early data with limited comparison states. States prohibiting fund supplantation showed significant increases in MOUD admissions.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Shi JS, Wen H
Citation:Shi JS, Wen H The Effect of Opioid Abatement Funds on the Utilization of Medications for Opioid Use Disorder. Health services research. 2026;61(6). doi:10.1111/1475-6773.70173